GlassScriptPhysician profile
Ayal Segal
NPI 1528191418
$457,247.33
in general payments reported to CMS, 2019-2025
8 companies · $126K in 2025
The $126K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $13K · 2021: $78K · 2022: $89K · 2023: $85K · 2024: $18K · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $206K · Consulting Fee: $20K · Travel and Lodging: $2,675 · Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $206,075.67 |
| Consulting Fee | $20,000.00 |
| Travel and Lodging | $2,674.97 |
| Food and Beverage | $718.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $450,589.53 | 2019-2025 | Djo Surgical |
| Djo, LLC | $4,787.50 | 2019 | |
| Wright Medical Technology, INC. | $694.18 | 2019 | |
| Zimmer Biomet Holdings, INC. | $531.31 | 2021-2023 | Tapestry |
| Stryker Corporation | $218.27 | 2024-2025 | Mako, Citrefix |
| Depuy Synthes Sales INC. | $211.46 | 2019 | |
| Think Surgical, INC. | $108.61 | 2024 | |
| Onkos Surgical, INC. | $106.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayal Segal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.